Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases

Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases

Copyright © 2015 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 157(2015), 2 vom: 07. Apr., Seite 114-20
1. Verfasser: Ichinose, Kunihiro (VerfasserIn)
Weitere Verfasser: Arima, Kazuhiko, Ushigusa, Takeshi, Nishino, Ayako, Nakashima, Yoshikazu, Suzuki, Takahisa, Horai, Yoshiro, Nakajima, Hideki, Kawashiri, Shin-Ya, Iwamoto, Naoki, Tamai, Mami, Nakamura, Hideki, Origuchi, Tomoki, Motomura, Masakatsu, Kawakami, Atsushi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Cerebrospinal fluid Cytokine profiles Neuropsychiatric systemic lupus erythematosus Weighted-voting algorithm Cytokines IL15 protein, human IL2 protein, human IL5 protein, human mehr... Interleukin-15 Interleukin-17 Interleukin-2 Interleukin-5 Fibroblast Growth Factor 2 103107-01-3 Interferon-gamma 82115-62-6
LEADER 01000naa a22002652 4500
001 NLM245995749
003 DE-627
005 20231224142116.0
007 cr uuu---uuuuu
008 231224s2015 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2015.01.010  |2 doi 
028 5 2 |a pubmed24n0820.xml 
035 |a (DE-627)NLM245995749 
035 |a (NLM)25656641 
035 |a (PII)S1521-6616(15)00029-7 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Ichinose, Kunihiro  |e verfasserin  |4 aut 
245 1 0 |a Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases 
264 1 |c 2015 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 29.06.2015 
500 |a Date Revised 18.03.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2015 Elsevier Inc. All rights reserved. 
520 |a Neuropsychiatric systemic lupus erythematosus (NPSLE) is a serious complication in SLE. Although the mechanism of NPSLE remains unclear, cytokines and chemokines are considered to be involved in their pathogenesis. Here we used Bio-Plex Pro assays to examine 27 types of cytokines and chemokines in the cerebrospinal fluid (CSF) of 32 NPSLE patients. We used the CSF of 20 patients with multiple sclerosis (MS) and 22 patients with neuromyelitis optica (NMO) as a disease control group. Fourteen of 27 cytokines/chemokines were significantly higher in the NPSLE patients compared to the MS/NMO patients. We could identify six "minimum predictive markers" by using a weighted-voting algorithm that could distinguish NPSLE from MS and NMO: interleukin (IL)-17, IL-2, interferon (IFN)-γ, IL-5, basic fibroblast growth factor (FGF)-basic and IL-15. The determination of various types of CSF cytokine profiles may contribute to the diagnosis of NPSLE and may help elucidate the mechanisms underlying this disease 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Cerebrospinal fluid 
650 4 |a Cytokine profiles 
650 4 |a Neuropsychiatric systemic lupus erythematosus 
650 4 |a Weighted-voting algorithm 
650 7 |a Cytokines  |2 NLM 
650 7 |a IL15 protein, human  |2 NLM 
650 7 |a IL2 protein, human  |2 NLM 
650 7 |a IL5 protein, human  |2 NLM 
650 7 |a Interleukin-15  |2 NLM 
650 7 |a Interleukin-17  |2 NLM 
650 7 |a Interleukin-2  |2 NLM 
650 7 |a Interleukin-5  |2 NLM 
650 7 |a Fibroblast Growth Factor 2  |2 NLM 
650 7 |a 103107-01-3  |2 NLM 
650 7 |a Interferon-gamma  |2 NLM 
650 7 |a 82115-62-6  |2 NLM 
700 1 |a Arima, Kazuhiko  |e verfasserin  |4 aut 
700 1 |a Ushigusa, Takeshi  |e verfasserin  |4 aut 
700 1 |a Nishino, Ayako  |e verfasserin  |4 aut 
700 1 |a Nakashima, Yoshikazu  |e verfasserin  |4 aut 
700 1 |a Suzuki, Takahisa  |e verfasserin  |4 aut 
700 1 |a Horai, Yoshiro  |e verfasserin  |4 aut 
700 1 |a Nakajima, Hideki  |e verfasserin  |4 aut 
700 1 |a Kawashiri, Shin-Ya  |e verfasserin  |4 aut 
700 1 |a Iwamoto, Naoki  |e verfasserin  |4 aut 
700 1 |a Tamai, Mami  |e verfasserin  |4 aut 
700 1 |a Nakamura, Hideki  |e verfasserin  |4 aut 
700 1 |a Origuchi, Tomoki  |e verfasserin  |4 aut 
700 1 |a Motomura, Masakatsu  |e verfasserin  |4 aut 
700 1 |a Kawakami, Atsushi  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 157(2015), 2 vom: 07. Apr., Seite 114-20  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:157  |g year:2015  |g number:2  |g day:07  |g month:04  |g pages:114-20 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2015.01.010  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 157  |j 2015  |e 2  |b 07  |c 04  |h 114-20